GlaxoSmithKline Pharmaceuticals on Friday said its consolidated net profit increased 12 per cent year-on-year to Rs 279 crore ...

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

GlaxoSmithKline Pharmaceuticals to launch oncology assets Jemperli and Zejula in India, addressing critical unmet needs in ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline today and set a price target of £13.97. The company’s shares opened today at p1,424.50. Take advantage of TipRanks Premium ...

In a report released on July 30, Nicolas Pauillac from Kepler Capital maintained a Hold rating on GlaxoSmithKline, with a price target of p1,500.00. The company’s shares closed yesterday at p1,418.00.

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...

GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

Health Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback In December, companies said early trials showed 'insufficient' immune response in older adults ...

Canada has had a deal with GlaxoSmithKline for influenza vaccines since 2001. The new agreement, which took effect July 1, was announced at GSK Canada in Quebec City, which employs 900 people.

GlaxoSmithKline has been implicated in a bribery scandal involving its sales representatives in China and paid a $3-billion US fine in the U.S. for marketing drugs for unapproved uses and ...